Rifamycin describes a group of macrocyclic antibiotic compounds primarily utilized for the treatment of tuberculosis and various bacterial infections by inhibiting bacterial DNA-dependent RNA polymerase.… Read more
































Rifamycin describes a group of macrocyclic antibiotic compounds primarily utilized for the treatment of tuberculosis and various bacterial infections by inhibiting bacterial DNA-dependent RNA polymerase. Laboratories rely on these high-quality compounds for comprehensive impurity profiling and rigorous quality control within pharmaceutical manufacturing. This category offers essential reference standards, including pharmacopeial and non-pharmacopeial impurities, along with critical metabolites and stable isotope labelled compounds. These materials are indispensable for validating analytical methods, ensuring precise identification of degradants, and monitoring the purity of the active pharmaceutical ingredient throughout the synthesis and development lifecycle. By utilizing these standardized reference materials, researchers can maintain strict compliance with regulatory standards and ensure accurate quantification during stability testing and routine analytical assays, facilitating reliable results in the evaluation of antibiotic drug products.